← Back to results

Sci Rep · 2022

Genome editing.

Scientific reports, 12(1): 20497 PMID 36443399 DOI 10.1038/s41598-022-24850-x

Open in PubMed ↗ Open via DOI ↗

Abstract

Recent advances in genome editing technologies have redefined our ability to probe and precisely edit the human genome and epigenome in vitro and in vivo. More specifically, RNA-guided CRISPR/Cas systems have revolutionized the field due to their simplicity in design and adaptability across biological systems. This Collection highlights results in CRISPR/Cas technology that increase the efficiency of precision genome editing, and allow genetic manipulation in model systems traditionally intractable to site-directed gene modification.

Cite